Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$28.84 - $38.92 $1,067 - $1,440
-37 Reduced 77.08%
11 $0
Q2 2022

Aug 08, 2022

SELL
$33.25 - $45.11 $66 - $90
-2 Reduced 4.0%
48 $2,000
Q1 2022

May 10, 2022

BUY
$40.68 - $49.72 $2,034 - $2,486
50 New
50 $2,000
Q4 2021

Feb 11, 2022

SELL
$43.21 - $57.6 $777 - $1,036
-18 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$52.8 - $60.32 $264 - $301
5 Added 38.46%
18 $1,000
Q3 2020

Nov 02, 2020

BUY
$37.98 - $48.72 $113 - $146
3 Added 30.0%
13 $1,000
Q2 2020

Aug 11, 2020

BUY
$31.07 - $44.74 $310 - $447
10 New
10 $0
Q1 2019

Apr 16, 2019

SELL
$41.26 - $58.35 $4,167 - $5,893
-101 Closed
0 $0
Q3 2018

Nov 02, 2018

SELL
$56.85 - $80.35 $1,819 - $2,571
-32 Reduced 24.06%
101 $0
Q2 2018

Jul 24, 2018

BUY
$35.85 - $57.05 $3,549 - $5,647
99 Added 291.18%
133 $0
Q4 2017

Feb 02, 2018

BUY
$28.0 - $33.2 $952 - $1,128
34
34 $1,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $539M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.